Search

everythinglearnresearchcommunity

for

Search:↓

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Alopecia areata involves immune response and gene changes affecting hair loss.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Higher DHT in male baldness may protect against prostate cancer.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

A woman's chronic headaches and hair loss were cured by treating her syphilis.

Microneedling is a promising, simple, and cost-effective treatment for hair loss that works well with other therapies.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Androgenetic alopecia is more common in Indian men than women, and family history is a strong risk factor.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Hair mass index is a precise way to measure hair loss in chemotherapy patients.

Men with androgenic alopecia have different hair copper levels than those without.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Female pattern baldness may indicate a higher risk of coronary artery disease.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Injecting a cell suspension from hair follicles increased hair density in a balding patient.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.